|
1
|
Komotar RJ, Schmidt JM, Starke RM,
Claassen J, Wartenberg KE, Lee K, Badjatia N, Connolly ES Jr and
Mayer SA: Resuscitation and critical care of poor-grade
subarachnoid hemorrhage. Neurosurgery. 64:397–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosengart AJ, Schultheiss KE, Tolentino J
and Macdonald RL: Prognostic factors for outcome in patients with
aneurysmal subarachnoid hemorrhage. Stroke. 38:2315–2321. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steiner T, Juvela S, Unterberg A, Jung C,
Forsting M and Rinkel G: European Stroke Organization guidelines
for the management of intracranial aneurysms and subarachnoid
haem-orrhage. Cerebrovasc Dis. 35:93–112. 2013. View Article : Google Scholar
|
|
4
|
Laskowitz DT and Kolls BJ: Neuroprotection
in subarachnoid hemorrhage. Stroke. 41(Suppl 10): S79–S84. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
MacDonald RL, Higashida RT, Keller E,
Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A,
et al: Clazosentan, an endothelin receptor antagonist, in patients
with aneurysmal subarachnoid haemorrhage undergoing surgical
clipping: a randomised, double-blind, placebo-controlled phase 3
trail (CONSCIOUS-2). Lancet Neurol. 10:618–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sehba FA, Hou J, Pluta RM and Zhang JH:
The importance of early brain injury after subarachnoid hemorrhage.
Prog Neurobiol. 97:14–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng G, Wei L, Zhi-Dan S, Shi-Guang Z and
Xiang-Zhen L: Atorvastatin ameliorates cerebral vasospasm and early
brain injury after subarachnoid hemorrhage and inhibits
caspase-dependent apoptosis pathway. BMC Neurosci. 10:72009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Budohoski KP, Czosnyka M, Kirkpatrick PJ,
Smielewski P, Steiner LA and Pickard JD: Clinical relevance of
cerebral autoregulation following subarachnoid haemorrhage. Nat Rev
Neurol. 9:152–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uekawa K, Hasegawa Y, Ma M, Nakagawa T,
Katayama T, Sueta D, Toyama K, Kataoka K, Koibuchi N, Kawano T, et
al: Rosuvastatin ameliorates early brain injury after subarachnoid
hemorrhage via suppression of superoxide formation and nuclear
factor-kappa B activation in rats. J Stroke Cerebrovasc Dis.
23:1429–1439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cahill J, Calvert JW, Solaroglu I and
Zhang JH: Vasospasm and p53-induced apoptosis in an experimental
model of subarachnoid hemorrhage. Stroke. 37:1868–1874. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Endo H, Nito C, Kamada H, Yu F and Chan
PH: Reduction in oxidative stress by superoxide dismutase
overexpression attenuates acute brain injury after subarachnoid
hemorrhage via activation of Akt/glycogen synthase kinase-3beta
survival signaling. J Cereb Blood Flow Metab. 27:975–982. 2007.
|
|
12
|
Aoki K, Zubkov AY, Ross IB and Zhang JH:
Therapeutic effect of caspase inhibitors in the prevention of
apoptosis and reversal of chronic cerebral vasospasm. J Clin
Neurosci. 9:672–677. 2002. View Article : Google Scholar
|
|
13
|
Sehba FA, Pluta RM and Zhang JH:
Metamorphosis of subarachnoid hemorrhage research: from delayed
vasospasm to early brain injury. Mol Neurobiol. 43:27–40. 201l.
View Article : Google Scholar
|
|
14
|
Tousoulis D, Antoniades C, Katsi V,
Bosinakou E, Kotsopoulou M, Tsioufis C and Stefanadis C: The impact
of early administration of low-dose atorvastatin treatment on
inflammatory process, in patients with unstable angina and low
cholesterol level. Int J Cardiol. 109:48–52. 2006. View Article : Google Scholar
|
|
15
|
Tseng MY, Czosnyka M, Richards H, Pickard
JD and Kirkpatrick PJ: Effects of acute treatment with pravastatin
on cerebral vasospasm, autoregulation, and delayed ischemic
deficits after aneurismal subarachnoid hemorrhage: a phase 2
randomized placebo-controlled trial. Stroke. 36:1627–1632. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee YM, Chen WF, Chou DS, Jayakumar T, Hou
SY, Lee JJ, Hsiao G and Sheu JR: Cyclic nucleotides and
mitogen-activated protein kinase: regulation of simvastatin in
platelet. J Biomed Sci. 17:452010. View Article : Google Scholar
|
|
17
|
Luzak B, Boncler M, Rywaniak J, Wilk R,
Stanczyk L, Czyz M, Rysz J and Watala C: The effect of a platelet
cholesterol modulation on the acetylsalicylic acid-madiated blood
platelet inhibition in hypercholesterolemic patients. Eur J
Pharmacol. 658:91–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou C, Yamaguchi M, Kusaka G, Schonholz
C, Nanda A and Zhang JH: Caspase inhibitors prevent endothelial
apoptosis and cerebral vasospasm in dog model of experimental
subarachnoid hemorrhage. J Cereb Blood Flow Metab. 24:419–431.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu
GQ, Liu HX, He WC, Sun XB, Huo L, et al: Potential contribution of
hypoxia-inducible factor-1α, aquaporin-4, and matrix
metalloproteinase-9 to blood-brain barrier disruption and brain
edema after experimental subarachnoid hemorrhage. J Mol Neurosci.
48:273–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chou SH, Smith EE, Badjatia N, Nogueira
RG, Sims JR, Ogilvy CS, Rordorf GA and Ayata C: A randomized,
double-blind, placebo-controlled pilot study of simvastatin in
aneurysmal subarachnoid hemorrhage. Stroke. 39:2891–2893. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garg K, Sinha S, Kale SS, Chandra PS, Suri
A, Singh MM, Kumar R, Sharma MS, Pandey RM, Sharma BS and Mahapatra
AK: Role of simvastatin in prevention of vasospasm and improving
functional outcome after aneurysmal subarachnoid hemorrhage: a
prospective, randomized, double-blind, placebo-controlled pilot
trial. Br J Neurosurg. 27:181–186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matthew J: Simvastatin for the prevention
of symptomatic cerebral vasospasm following aneurysmal subarachnoid
hemorrhage: a single-institution prospective cohort study. J
Neurosurg. 110:968–974. 2009. View Article : Google Scholar
|
|
23
|
Kirkpatrick PJ, Turner CL, Smith C,
Hutchinson PJ and Murray GD; STASH Collaborators: Simvastatin in
aneurysmal subarachnoid haemorrhage(STASH): a multicentre
randomised phase 3 trial. Lancet Neurol. 13:666–675. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vergouwen MD, Meijers JC, Geskus RB, Coert
BA, Horn J, Stroes ES, van der Poll T, Vermeulen M and Roos YB:
Biologic effects of simvastatin in patients with aneurysmal
subarachnoid hemorrhage: a double-blind, placebo-controlled
randomized trial. J Cereb Blood Flow Metab. 29:1444–1453. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J, Chen G, Li J, Qian C, Mo H, Gu C,
Yan F, Yan W and Wang L: Melatonin attenuates inflammatory
response-induced brain edema in early brain injury following a
subarachnoid hemorrhage: a possible role for the regulation of
pro-inflammatory cytokines. J Pineal Res. 57:340–347. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang CZ, Wu SC, Kwan AL and Lin CL:
Preconditioning with pitavastatin, an HMG-CoA reductase inhibitor,
attenuates C-Jun N-terminal kinase activation in experimental
subarachnoid hemorrhage-induced apoptosis. Acta Neurochi.
157:1031–1041. 2015. View Article : Google Scholar
|
|
27
|
Broderick JP, Brott TG, Duldner JE,
Tomsick T and Leach A: Initial and recurrent bleeding are the major
causes of death following subarachnoid hemorrhage. Stroke.
25:1342–1347. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Claassen J, Carhuapoma JR, Kreiter KT, Du
EY, Connolly ES and Mayer SA: Global cerebral edema after
subarachnoid hemorrhage: frequency, prediction, and impact on
outcome. Stroke. 33:1225–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosell A, Cuadrado E, Ortega-Aznar A,
Hernandez-Guillamon M, Lo EH and Montaner J: MMP-9-positive
neutrophil infiltration is associated to blood-brain barrier
breakdown and basal lamina type IV collagen degradation during
hemorrhagic transformation after human ischemic stroke. Stroke.
39:1121–1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosenberg GA and Navratil M:
Metalloproteinase inhibition blocks edema in intracerebral
hemorrhage in the rat. Neurology. 48:921–926. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramos-Fernandez M, Fernanda Bellolio M and
Stead LG: Matrix metalloproteinase-9 as a marker for acute ischemic
stroke:a systematic review. J Stroke Cerebrovasc Dis. 20:47–54.
2011. View Article : Google Scholar
|
|
32
|
Papadopoulous MC and Verkman AS:
Aquaporin-4 gene disruption in mice reduces brain swelling and
mortality in pneumococcal meningitis. J Biol Chem. 280:13906–13912.
2005. View Article : Google Scholar
|
|
33
|
Manley GT, Fujimura M, Ma T, Noshita N,
Filiz F, Bollen AW, Chan P and Verkman AS: Aquaporin-4 deletion in
mice reduces brain edema after acute water intoxication and
ischemic stroke. Nat Med. 6:159–163. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang B, Zador Z and Verkman AS: G1ial cell
aquaporin-4 overexpression in transgenic mice accelerates cytotoxic
brain swelling. J Biol Chem. 283:15280–15286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abbott NJ and Patabendige AA: Structure
and function of the blood-brain barrier. Neurobiol Dis. 37:13–25.
2010. View Article : Google Scholar
|
|
36
|
Hawkins BT and Davis TP: The blood-brain
barrier/neurovascular unit in health and disease. Pharmacol Rev.
57:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Terry S, Nie M, Matter K and Balda MS: Rho
signaling and tight junction functions. Physiology (Bethesda).
25:16–26. 2010. View Article : Google Scholar
|
|
38
|
Huber JD, Egletun RD and Davis TP:
Molecular physiology and pathophysiology of tight junctions in the
blood-brain barrier. Trends Neurosci. 24:719–725. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Persidsky Y, Ramirez SH, Haorah J and
Kanmogne GD: Blood-brain barrier: structural components and
function under physiologic and pathologic conditions. J Neuroimmune
Pharmacol. 1:223–236. 2006. View Article : Google Scholar
|
|
40
|
Yi R, Gao X-P and Hui L: Atorvastatin
prevents angiotensin II-induced high permeability of human arterial
endothelial cell monolayers via ROCK signaling pathway. Biochem
Biophys Res Commun. 459:94–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Garrido JM, Esteban M, Roda O, Alaminos M
and Sánchez-Montesinos I: Lysophosphatidic acid pretreatment
prevents micromolar atorvastatin-induced endothelial cell death and
ensures the beneficial effects of high-concentration statin therapy
on endothelial gene expression. Ann Vasc Surg. 26:549–558. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kalayci R, Kaya M, Elmas I, Arican N,
Ahishali B, Uzun H, Bilgic B, Kucuk M and Kudat H: Effects of
atorvastatin on blood-brain barrier permeability during l-NAME
hypertension followed by angiotensin-II in rats. Brain Res.
1042:184–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Seo JH1, Guo S, Lok J, Navaratna D, Whalen
MJ, Kim KW and Lo EH: Neurovascular matrix metalloproteinases and
the blood-brain barrier. Curr Pharm Des. 18:3645–3648. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu MX, Lu C, Xia CM, Qiao Z and Zhu D:
Simvastatin pretreatment protects cerebrum from neuronal injury by
decreasing the expressions of phosphor-CaMK II and AQP4 in ischemic
stroke rats. J Mol Neurosci. 54:591–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wong GK, Chan DY, Siu DY, Zee BCY, Poon
WS, Chan MTV, Gin T and Leung M: High-dose simvastatin for
aneurysmal subarachnoid hemorrhage: multicenter randomized
controlled double-blinded clinical trial. Stroke. 46:382–388. 2015.
View Article : Google Scholar
|
|
46
|
Chow M, Dumont AS and Kasselletal NF:
Endothelin receptor antagonists and cerebral vasospasm: an update.
Neurosurgery. 51:1333–1342. 2002.PubMed/NCBI
|
|
47
|
Wang LK, Hong Z, Wu GF and Li C:
Perihematomal endothelin-1 level is associated with an increase in
blood-brain barrier permeability in a rabbit model of intracerebral
hematoma. Chin Med J (Engl). 126:3433–3438. 2013.
|
|
48
|
Michinaga S, Nagase M, Matsuyama E,
Yamanaka D, Seno N, Fuka M, Yamamoto Y and Koyama Y: Amelioration
of cold injury-induced cortical brain edema formation by selective
endothelin ETB receptor antagonists in mice. PLoS One.
9:e1020092014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jo SM, Ryu HJ, Kim JE, Yeo SI, Kim MJ,
Choi HC, Song HK and Kang TC: Up-regulation of endothelial
endothelin-1 expression prior to vasogenic edema formation in the
rat piriform cortex following status epilepticus. Neurosci Lett.
501:25–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Manley GT, Binder DK, Papadopoulos MC and
Verkman AS: New insights into water transport and edema in the
central nervous system from phenotype analysis of aquaporin-4 null
mice. Neuroscience. 129:983–991. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Migliati E, Meurice N, DuBois P, Fang JS,
Somasekharan S, Beckett E, Flynn G and Yool AJ: Inhibition of
aquaporin-1 and aquaporin-4 water permeability by a derivative of
the loop diuretic bumetanide acting at an internal pore-occluding
binding site. Mol Pharmacol. 76:105–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu
GQ, Liu HX, He WC, Sun XB, Huo L, et al: Potential contribution of
hypoxia-inducible factor-1α, aquaporin-4, and matrix
metalloproteinase-9 to blood-brain barrier disruption and brain
edema after experimental subarachnoid hemorrhage. J Mol Neurosci.
48:273–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang WW, Xie C, Zhou LL and Wang GS: The
function of aquaporin4 in ischemic brain edema. Clin Neurol
Neurosurg. 127:5–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Alnemri ES, Livingston DJ, Nicholson DW,
Salvesen G, Thomberry NA, Wong WW and Yuan J: Human ICE/CED-3
protease nomenclature. Cell. 87:1711996. View Article : Google Scholar : PubMed/NCBI
|
